Diamond Therapeutics
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
100 King St W Suite 6200, Toronto, Ontar...Website
www.diamondthera.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Diamond Therapeutics
Diamond Therapeutics is a psychedelic pharmaceutical company focused on developing safe, FDA, EMA, and Health Canada approved therapies for neuropsychiatric conditions. Their primary product line includes sub-perceptual psilocybin-based medicines aimed at providing more effective treatment options than current first-line therapies. The company is dedicated to creating well-tolerated interventions that can benefit a wide range of patient groups, addressing the global mental health crisis. With a team of experts in neuroscience and pharmacology, Diamond Therapeutics is advancing a diverse pipeline of innovative drug candidates.Explore more
Diamond Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Diamond Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Diamond Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Diamond Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Diamond Therapeutics launches new products
Check if Diamond Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Diamond Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Diamond Therapeutics recently announced quarterly report
Click to see if Diamond Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Diamond Therapeutics has new funding data
Recommended Actions
Reach out to Masked Content who joined Diamond Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Diamond Therapeutics
Compare insights from companies similar to Diamond Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Diamond Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Diamond Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Diamond Therapeutics.
Diamond Therapeutics Tech Stack
A closer look at the technologies used by Diamond Therapeutics
Diamond Therapeutics News & Media
Diamond Therapeutics Welcomes White House Executive Order on Research into Psychedelics for Mental Health Treatment
Company now conducting Phase 2 clinical trial using low doses of psilocybin for treatment of generalized anxiety disorder TORONTO, ON, CANADA, April 20, 2026 /EINPresswire.com/ -- Diamond Therapeutics Inc., a clinical-stage drug development company …Diamond Therapeutics Announces First Patient Enrolled in FDA-authorized Study Evaluating Low-Dose Psilocybin in Human Subjects with Demoralization
The trial is being conducted at the University of Alabama at Birmingham (UAB) under noted psychedelic researcher Dr. Peter Hendricks This exploratory study is the first investigation of the influence of low-dose psilocybin on human subjects suffering from demoralization TORONTO, Oct. 17,...First Avenue Ventures Life Science Fund I Invests in Diamond Therapeutics to Accelerate Innovation in Mental Health
TORONTO, April 4, 2023 /PRNewswire/ - Diamond Therapeutics Inc. ("Diamond"), a drug development company focused on low-dose psychedelic-derived therapies for use in the treatment of mental health, is pleased to announce a strategic investment round led by First Avenue Ventures Life...Diamond Therapeutics Announces FDA-authorized Clinical Trial of Low-Dose Psilocybin in Collaboration with University of Alabama at Birmingham
The Investigational New Drug application (IND) for this trial has been cleared by the United States Food and Drug Administration (FDA) The study investigates the effects of repeat low-dose psilocybin on demoralization The trial will be conducted at the University of Alabama at Birmingham...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Diamond Therapeutics
Sign Up For FreeTo access detailed company insights
Diamond Therapeutics is a psychedelic pharmaceutical company focused on developing safe, FDA, EMA, and Health Canada approved therapies for neuropsychiatric conditions. Their primary product line includes sub-perceptual psilocybin-based medicines aimed at providing more effective treatment options than current first-line therapies. The company is d... Read More
